By Mill Chart
Last update: May 19, 2025
CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) stands out as a compelling candidate for high growth momentum investors, combining strong earnings momentum with a favorable technical breakout pattern. The stock meets rigorous screening criteria with a High Growth Momentum Rating of 7, a Technical Rating of 9, and a Setup Rating of 8.
For a deeper technical assessment, review the full technical report for CPRX.
Our High Growth Momentum Breakout Setups Screen identifies similar opportunities daily.
This is not investment advice. Always conduct your own research before making financial decisions.
22.81
-0.41 (-1.77%)
Find more stocks in the Stock Screener
CATALYST PHARMACEUTICALS (CPRX) offers strong growth, solid profitability, and an attractive valuation, making it a standout in biotech.
CATALYST PHARMACEUTICALS (CPRX) meets CANSLIM criteria with strong earnings growth, high relative strength, and solid fundamentals. A technical uptrend and reasonable valuation add to its appeal.
CATALYST PHARMACEUTICALS INC (CPRX) meets key growth criteria from Louis Navellier’s strategy, with strong earnings, revenue growth, and solid financial health. A detailed analysis highlights its potential for investors.